Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Proellex shows superior efficacy and safety in endometriosis compared to Lucrin

June 15, 2007

GEM OS1 Bone Graft begins pivotal study in E.U.

June 15, 2007

Kissei and Eisai agree to develop and market Glufast in 10 ASEAN countries

June 14, 2007

BioSante and Teva reinitiate male testosterone therapy development

June 14, 2007

7TM Pharma initiates phase II clinical study of obinepitide for obesity

June 14, 2007

Japanese launch for Myozyme

June 13, 2007

KB-2115 completes proof-of-concept phase II study in dyslipidemia

June 13, 2007

SBG enters phase III for diabetic ulcers

June 13, 2007

Tanabe Seiyaku reports proof of concept for SGLT-2 inhibitor

June 13, 2007

Japanese orphan drug designation for Naglazyme

June 12, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...